Defective Treg generation and increased type 3 immune response in leukocyte adhesion deficiency 1

Defective Treg generation and increased type 3 immune response in leukocyte adhesion deficiency 1

Copyright © 2023 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 253(2023) vom: 30. Aug., Seite 109691
1. Verfasser: Erdem, Serife (VerfasserIn)
Weitere Verfasser: Haskologlu, Sule, Haliloglu, Yesim, Celikzencir, Huriye, Arik, Elif, Keskin, Ozlem, Eltan, Sevgi Bilgic, Yucel, Esra, Canatan, Halit, Avcilar, Huseyin, Yilmaz, Ebru, Ozcan, Alper, Unal, Ekrem, Karakukcu, Musa, Celiksoy, Mehmet Halil, Kilic, Sara Sebnem, Demir, Ayca, Genel, Ferah, Gulez, Nesrin, Koker, Mustafa Yavuz, Ozen, Ahmet Oguzhan, Baris, Safa, Metin, Ayse, Guner, Sukru Nail, Reisli, Ismail, Keles, Sevgi, Dogu, Esin Figen, Ikinciogullari, Kamile Aydan, Eken, Ahmet
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't ILC LAD-1 Leukocyte adhesion deficiency Th17 Treg
LEADER 01000naa a22002652 4500
001 NLM359343929
003 DE-627
005 20231226080654.0
007 cr uuu---uuuuu
008 231226s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2023.109691  |2 doi 
028 5 2 |a pubmed24n1197.xml 
035 |a (DE-627)NLM359343929 
035 |a (NLM)37433423 
035 |a (PII)S1521-6616(23)00454-0 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Erdem, Serife  |e verfasserin  |4 aut 
245 1 0 |a Defective Treg generation and increased type 3 immune response in leukocyte adhesion deficiency 1 
264 1 |c 2023 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 26.07.2023 
500 |a Date Revised 26.07.2023 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2023 Elsevier Inc. All rights reserved. 
520 |a In 15 Turkish LAD-1 patients and controls, we assessed the impact of pathogenic ITGB2 mutations on Th17/Treg differentiation and functions, and innate lymphoid cell (ILC) subsets. The percentage of peripheral blood Treg cells, in vitro-generated induced Tregs differentiated from naive CD4+ T cells were decreased despite the elevated absolute counts of CD4+ cells in LAD-1 patients. Serum IL-23 levels were elevated in LAD-1 patients. Post-curdlan stimulation, LAD-1 patient-derived PBMCs produced more IL-17A. Additionally, the percentages of CD18-deficient Th17 cells expanded from total or naïve CD4+ T cells were higher. The blood ILC3 subset was significantly elevated in LAD-1. Finally, LAD-1 PBMCs showed defects in trans-well migration and proliferation and were more resistant to apoptosis. Defects in de novo generation of Tregs from CD18-deficient naïve T cells and elevated Th17s, and ILC3s in LAD-1 patients' peripheral blood suggest a type 3-skewed immunity and may contribute to LAD-1-associated autoimmune symptoms 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a ILC 
650 4 |a LAD-1 
650 4 |a Leukocyte adhesion deficiency 
650 4 |a Th17 
650 4 |a Treg 
700 1 |a Haskologlu, Sule  |e verfasserin  |4 aut 
700 1 |a Haliloglu, Yesim  |e verfasserin  |4 aut 
700 1 |a Celikzencir, Huriye  |e verfasserin  |4 aut 
700 1 |a Arik, Elif  |e verfasserin  |4 aut 
700 1 |a Keskin, Ozlem  |e verfasserin  |4 aut 
700 1 |a Eltan, Sevgi Bilgic  |e verfasserin  |4 aut 
700 1 |a Yucel, Esra  |e verfasserin  |4 aut 
700 1 |a Canatan, Halit  |e verfasserin  |4 aut 
700 1 |a Avcilar, Huseyin  |e verfasserin  |4 aut 
700 1 |a Yilmaz, Ebru  |e verfasserin  |4 aut 
700 1 |a Ozcan, Alper  |e verfasserin  |4 aut 
700 1 |a Unal, Ekrem  |e verfasserin  |4 aut 
700 1 |a Karakukcu, Musa  |e verfasserin  |4 aut 
700 1 |a Celiksoy, Mehmet Halil  |e verfasserin  |4 aut 
700 1 |a Kilic, Sara Sebnem  |e verfasserin  |4 aut 
700 1 |a Demir, Ayca  |e verfasserin  |4 aut 
700 1 |a Genel, Ferah  |e verfasserin  |4 aut 
700 1 |a Gulez, Nesrin  |e verfasserin  |4 aut 
700 1 |a Koker, Mustafa Yavuz  |e verfasserin  |4 aut 
700 1 |a Ozen, Ahmet Oguzhan  |e verfasserin  |4 aut 
700 1 |a Baris, Safa  |e verfasserin  |4 aut 
700 1 |a Metin, Ayse  |e verfasserin  |4 aut 
700 1 |a Guner, Sukru Nail  |e verfasserin  |4 aut 
700 1 |a Reisli, Ismail  |e verfasserin  |4 aut 
700 1 |a Keles, Sevgi  |e verfasserin  |4 aut 
700 1 |a Dogu, Esin Figen  |e verfasserin  |4 aut 
700 1 |a Ikinciogullari, Kamile Aydan  |e verfasserin  |4 aut 
700 1 |a Eken, Ahmet  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 253(2023) vom: 30. Aug., Seite 109691  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:253  |g year:2023  |g day:30  |g month:08  |g pages:109691 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2023.109691  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 253  |j 2023  |b 30  |c 08  |h 109691